Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
CytoDyn Inc CYDY
(Total Views: 707)
Posted On: 12/11/2023 9:49:58 AM
Post# of 154605
Posted By: ohm20
Grip it, the problem with HIV vaccines is that the HIV virus occupies the CCR5 receptor crippling the immune response. Infection triggers an increase in CD4/CCR5 T-cells but they are killed off quickly by HIV reproduction. That cycle greatly decreases the production of CD8 T-cells. So even with an antibody response in place there are few CD8 T-cells. The vaccines may produce a T-cell antibody response until HIV starts it's very rapid reproduction, then there's not enough CD8 T-cells to mount an effective response.

You would first have to use antiretrovirals or leronlimab to knock down the virus or use them as PREP. Since other drugs would carry the load then there's not much for the vaccines to do.
















(19)
(0)









  • New Post - Investors HangoutNew Post

  • Public Reply - Investors HangoutPublic Reply

  • Private Reply - Investors HangoutPrivate Reply

  • Board - Investors HangoutBoard

  • More - Investors HangoutMore

  • Keep Post - Investors HangoutKeep Post
  • Report Post - Investors HangoutReport Post
  • Home - Investors HangoutHome
  • Mailbox - Investors HangoutMailbox
  • Boards - Investors HangoutBoards
  • Favorites - Investors HangoutFavorites
  • Whats Hot! - Investors HangoutWhats Hot!
  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site